Prostaglandin D2 Receptor 2 Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4145279
- 97 Pages
- December 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Prostaglandin D2 Receptor 2 market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Prostaglandin D2 Receptor 2 market segmented into
OC-2417
MK-1029
BBI-5000
ADC-7405
Others
Based on the end-use, the global Prostaglandin D2 Receptor 2 market classified into
Atopic Dermatitis
Allergic Asthma
Chronic Obstructive Pulmonary Disease
Others
Based on geography, the global Prostaglandin D2 Receptor 2 market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Allergan Plc
Brickell Biotech, Inc.
Ligand Pharmaceuticals, Inc.
Merck & Co., Inc.
Novartis AG
Oxagen Limited
Panmira Pharmaceuticals, LLC.
Pulmagen Therapeutics LLP
Taisho Pharmaceutical Holdings Co., Ltd.
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL PROSTAGLANDIN D2 RECEPTOR 2 INDUSTRY
2.1 Summary about Prostaglandin D2 Receptor 2 Industry
2.2 Prostaglandin D2 Receptor 2 Market Trends
2.2.1 Prostaglandin D2 Receptor 2 Production & Consumption Trends
2.2.2 Prostaglandin D2 Receptor 2 Demand Structure Trends
2.3 Prostaglandin D2 Receptor 2 Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 OC-2417
4.2.2 MK-1029
4.2.3 BBI-5000
4.2.4 ADC-7405
4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Atopic Dermatitis
4.3.2 Allergic Asthma
4.3.3 Chronic Obstructive Pulmonary Disease
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 OC-2417
5.2.2 MK-1029
5.2.3 BBI-5000
5.2.4 ADC-7405
5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Atopic Dermatitis
5.3.2 Allergic Asthma
5.3.3 Chronic Obstructive Pulmonary Disease
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 OC-2417
6.2.2 MK-1029
6.2.3 BBI-5000
6.2.4 ADC-7405
6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Atopic Dermatitis
6.3.2 Allergic Asthma
6.3.3 Chronic Obstructive Pulmonary Disease
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 OC-2417
7.2.2 MK-1029
7.2.3 BBI-5000
7.2.4 ADC-7405
7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Atopic Dermatitis
7.3.2 Allergic Asthma
7.3.3 Chronic Obstructive Pulmonary Disease
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 OC-2417
8.2.2 MK-1029
8.2.3 BBI-5000
8.2.4 ADC-7405
8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Atopic Dermatitis
8.3.2 Allergic Asthma
8.3.3 Chronic Obstructive Pulmonary Disease
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 OC-2417
9.2.2 MK-1029
9.2.3 BBI-5000
9.2.4 ADC-7405
9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Atopic Dermatitis
9.3.2 Allergic Asthma
9.3.3 Chronic Obstructive Pulmonary Disease
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Allergan Plc
10.1.2 Brickell Biotech, Inc.
10.1.3 Ligand Pharmaceuticals, Inc.
10.1.4 Merck & Co., Inc.
10.1.5 Novartis AG
10.1.6 Oxagen Limited
10.1.7 Panmira Pharmaceuticals, LLC.
10.1.8 Pulmagen Therapeutics LLP
10.1.9 Taisho Pharmaceutical Holdings Co., Ltd.
10.2 Prostaglandin D2 Receptor 2 Sales Date of Major Players (2017-2020e)
10.2.1 Allergan Plc
10.2.2 Brickell Biotech, Inc.
10.2.3 Ligand Pharmaceuticals, Inc.
10.2.4 Merck & Co., Inc.
10.2.5 Novartis AG
10.2.6 Oxagen Limited
10.2.7 Panmira Pharmaceuticals, LLC.
10.2.8 Pulmagen Therapeutics LLP
10.2.9 Taisho Pharmaceutical Holdings Co., Ltd.
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
Table Prostaglandin D2 Receptor 2 Product Type Overview
Table Prostaglandin D2 Receptor 2 Product Type Market Share List
Table Prostaglandin D2 Receptor 2 Product Type of Major Players
Table Brief Introduction of Allergan Plc
Table Brief Introduction of Brickell Biotech, Inc.
Table Brief Introduction of Ligand Pharmaceuticals, Inc.
Table Brief Introduction of Merck & Co., Inc.
Table Brief Introduction of Novartis AG
Table Brief Introduction of Oxagen Limited
Table Brief Introduction of Panmira Pharmaceuticals, LLC.
Table Brief Introduction of Pulmagen Therapeutics LLP
Table Brief Introduction of Taisho Pharmaceutical Holdings Co., Ltd.
Table Products & Services of Allergan Plc
Table Products & Services of Brickell Biotech, Inc.
Table Products & Services of Ligand Pharmaceuticals, Inc.
Table Products & Services of Merck & Co., Inc.
Table Products & Services of Novartis AG
Table Products & Services of Oxagen Limited
Table Products & Services of Panmira Pharmaceuticals, LLC.
Table Products & Services of Pulmagen Therapeutics LLP
Table Products & Services of Taisho Pharmaceutical Holdings Co., Ltd.
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Prostaglandin D2 Receptor 2 Market Forecast (Million USD) by Region 2021f-2026f
Table Global Prostaglandin D2 Receptor 2 Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Prostaglandin D2 Receptor 2 Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Prostaglandin D2 Receptor 2 Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
